Share Us: Subscribe | Contact

Biblio

Export 3139 results:

Tagged

Author Title Type [ Year

]

2016

M. Berger, Nadler, J. W., Friedman, A., McDonagh, D. L., Bennett, E. R., Cooter, M., Qi, W., Laskowitz, D. T., Ponnusamy, V., Newman, M. F., Shaw, L. M., Warner, D. S., Mathew, J. P., and James, M. L., “The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.

G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.

M. Venturelli, Sollima, A., Cè, E., Limonta, E., Bisconti, A. V., Brasioli, A., Muti, E., and Esposito, F., “Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1631-40, 2016.

S. Vandepitte, Van Den Noortgate, N., Putman, K., Verhaeghe, S., Faes, K., and Annemans, L., “Effectiveness of Supporting Informal Caregivers of People with Dementia: A Systematic Review of Randomized and Non-Randomized Controlled Trials.”, J Alzheimers Dis, vol. 52, no. 3, pp. 929-65, 2016.

R. A. Mudar, Chiang, H. - S., Eroh, J., Nguyen, L. T., Maguire, M. J., Spence, J. S., Kung, F., Kraut, M. A., and Hart, J., “The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials.”, J Alzheimers Dis, vol. 50, no. 2, pp. 577-90, 2016.

E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., “Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.

T. Porter, Bharadwaj, P., Groth, D., Paxman, A., Laws, S. M., Martins, R. N., and Verdile, G., “The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.”, J Alzheimers Dis, vol. 50, no. 3, pp. 895-905, 2016.

J. Wang, Ye, F., Cheng, X., Zhang, X., Liu, F., Liu, G., Ni, M., Qiao, S., Zhou, W., and Zhang, Y., “The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 907-19, 2016.

K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., “Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1277-98, 2016.

H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., “Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.

M. Tsolaki, Karathanasi, E., Lazarou, I., Dovas, K., Verykouki, E., Karacostas, A., Georgiadis, K., Tsolaki, A., Adam, K., Kompatsiaris, I., and Sinakos, Z., “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.”, J Alzheimers Dis, vol. 54, no. 1, pp. 129-33, 2016.

G. Liu, Weinger, J. G., Lu, Z. - L., Xue, F., and Sadeghpour, S., “Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 49, no. 4, pp. 971-90, 2016.

A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., “Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.”, J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.

Y. Yoshino, Mori, T., Yoshida, T., Yamazaki, K., Ozaki, Y., Sao, T., Funahashi, Y., Iga, J. - I., and Ueno, S. - I., “Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1349-1357, 2016.

H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.

B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., “Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.

B. Cretin, Sellal, F., Philippi, N., Bousiges, O., Di Bitonto, L., Martin-Hunyadi, C., and Blanc, F., “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.

V. Chouraki, Reitz, C., Maury, F., Bis, J. C., Bellenguez, C., Yu, L., Jakobsdottir, J., Mukherjee, S., Adams, H. H., Choi, S. Hoan, Larson, E. B., Fitzpatrick, A., Uitterlinden, A. G., De Jager, P. L., Hofman, A., Gudnason, V., Vardarajan, B., Ibrahim-Verbaas, C., van der Lee, S. J., Lopez, O., Dartigues, J. - F., Berr, C., Amouyel, P., Bennett, D. A., van Duijn, C., DeStefano, A. L., Launer, L. J., M Ikram, A., Crane, P. K., Lambert, J. - C., Mayeux, R., and Seshadri, S., “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.

M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.

M. Ettcheto, Petrov, D., Pedrós, I., Alva, N., Carbonell, T., Beas-Zarate, C., Pallas, M., Auladell, C., Folch, J., and Camins, A., “Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 233-51, 2016.

I. E. van de Vorst, Koek, H. L., Bots, M. L., and Vaartjes, I., “Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning.”, J Alzheimers Dis, vol. 53, no. 1, pp. 117-25, 2016.

T. Jayne, Newman, M., Verdile, G., Sutherland, G., Münch, G., Musgrave, I., Nik, S. Hani Mouss, and Lardelli, M., “Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 781-99, 2016.

S. Hsieh, Leyton, C. E., Caga, J., Flanagan, E., Kaizik, C., O'Connor, C. M., Kiernan, M. C., Hodges, J. R., Piguet, O., and Mioshi, E., “The Evolution of Caregiver Burden in Frontotemporal Dementia with and without Amyotrophic Lateral Sclerosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 875-85, 2016.

R. David, Manera, V., Fabre, R., Pradier, C., Robert, P., and Tifratene, K., “Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).”, J Alzheimers Dis, vol. 53, no. 4, pp. 1365-73, 2016.

F. Kumfor, Teo, D., Miller, L., Lah, S., Mioshi, E., Hodges, J. R., Piguet, O., and Irish, M., “Examining the Relationship Between Autobiographical Memory Impairment and Carer Burden in Dementia Syndromes.”, J Alzheimers Dis, vol. 51, no. 1, pp. 237-48, 2016.

Pages